Emily Cline, MD
Gynecology · Whiteland, INNPI 1023125440
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Duchesnay USA Incorporated at 37.6% of the total. Reporting peaked in 2019 at $5,413 and has fallen 90.6% since, to $510 in 2025. Among gynecology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 204 payments — averaging $57.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Duchesnay USA Incorporated$4K
- Axonics, Inc.$3K
- Boston Scientific$1K
- Applied Medical Resources Corporation$651
- Astellas Pharma US Inc$365
- AbbVie$312
- plus $2K from 25 others
What the payments were for
- Speaking & faculty fees$4,00034%
- Travel & lodging$2,93725%
- Food & beverage$4,58639%
- Education$1391%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Duchesnay USA Incorporated | 19 | $4,385 |
| Axonics, Inc. | 54 | $3,058 |
| Boston Scientific | 11 | $1,136 |
| Applied Medical Resources Corporation | 2 | $651 |
| Astellas Pharma US Inc | 12 | $365 |
| AbbVie | 16 | $312 |
| Bayer | 15 | $250 |
| Coopersurgical, Inc. | 7 | $192 |
| Mayne Pharma Commercial LLC | 11 | $186 |
| Medtronic(2 entities) | 9 | $165 |
| Exeltis, USA Inc. | 9 | $135 |
| Hologic Sales And Service, LLC | 3 | $122 |
| Therapeuticsmd, Inc. | 7 | $115 |
| Pfizer | 5 | $100 |
| Coloplast | 3 | $98 |
| Amgen | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| Millicent US Inc | 2 | $42 |
| Johnson & Johnson | 1 | $37 |
| Vertical Pharmaceuticals, LLC | 2 | $28 |
| Caldera Medical, Inc | 1 | $25 |
| Roche Diagnostics Corporation | 1 | $25 |
| Agiliti Surgical, Inc. | 1 | $24 |
| Exact Sciences | 1 | $22 |
| Innovation Technologies Inc | 1 | $21 |
| GRT US Holding, Inc. | 1 | $19 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Mallinckrodt Enterprises LLC | 1 | $12 |
| Minerva Surgical, Inc | 1 | $12 |
| Mission Pharmacal Company | 1 | $11 |
| Meditrina | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Osphena$4,226
- Axonics$1,226
- Axonics r-SNM System$886
- Bulkamid$878
- SOLYX$780
- GelPOINT V-Path$619
How this compares
$11,662 in reported general payments places this provider in the 95th percentile of 30 gynecology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 153 | $84,817 |
| GemtesaVibegron | 33 | $30,489 |
| Mirabegron ErMirabegron | 23 | $16,247 |
| Estradiol | 193 | $11,742 |
| YuvafemEstradiol | 74 | $6,536 |
| Tolterodine Tartrate ErTolterodine Tartrate | 19 | $2,186 |
| Oxybutynin Chloride ErOxybutynin Chloride | 55 | $2,108 |
| Solifenacin Succinate | 70 | $1,359 |
| Trimethoprim | 29 | $1,346 |
| Raloxifene Hcl | 36 | $1,042 |
| Estradiol (Once Weekly)Estradiol | 14 | $926 |
| ValacyclovirValacyclovir Hcl | 18 | $923 |
| Clobetasol Propionate | 29 | $626 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 18 | $596 |
| ProgesteroneProgesterone, Micronized | 21 | $558 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $365 | $84,817153 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $42 | $30,48933 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 30 gynecology providers in Indiana.
Other gynecology in Whiteland
- Kevin MillerLafayette$15K
- Joel McCuaigWest Lafayette$4K
- Bryan PerkinsIndianapolis$4K
- Anthony IwuagwuGary$3K
- Pamela StoneGoshen$3K
- Robert PerryRushville$3K
- Michelle MurphyIndianapolis$3K
- Madalyn SquiresIndianapolis$2K
- Jill GreenJeffersonville$2K
- Landon HarrisonFort Wayne$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.